Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion type Assertion NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_head.
- NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion description "[To quantify MRD in patients after anti-CD22 recombinant immunotoxin BL22 and other agents, we used a relative quantitative PCR (RQ-PCR) assay using a primer and probe, both patient specific for the immunoglobulin heavy chain rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_provenance.
- NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion evidence source_evidence_literature NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_provenance.
- NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion SIO_000772 16675574 NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_provenance.
- NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion wasDerivedFrom befree-20150227 NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_provenance.
- NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_assertion wasGeneratedBy ECO_0000203 NP291281.RAkvflpnqcmN68Ntl3j5D5r-gFnvuguGtmzmqTxf64To8130_provenance.